Abstract:Objectives To describe the clinical characteristics of Chinese cystic fibrosis (CF) patients and to investigate the variants of CFTR and their potential pathogenicity. Study design Chinese patients with potential CF diagnosis were studied. Clinical data were reviewed retrospectively from medical records. Whole exome sequencing and genetic evaluation was conducted to explore potential gene variants. The disruption of the variants to protein structure and function was explored and validated using in vitro experiments and in silico analysis. Results Four patients were recruited to the study, three of them were diagnosed as CF, and one was diagnosed as CFTR-related disorder. The age at symptom onset for the patients in this study ranged from newborn to 6 years, while the age at diagnosis varied from 3 to 11 years. All four patients exhibited bilateral diffuse bronchiectasis with Pseudomonas aeruginosa infections, and three of them had malnutrition. Finger clubbing was observed in three patients, two of whom displayed mixed ventilatory dysfunction. The CFTR variants spectrum of Chinese children with CF differs from that of Caucasian. A total of six variants were identified, two of which were first reported (c.1219G>T [p.Glu407*] and c.1367delT [p.Ala457Leufs*12]). The nonsense variants c.1219G>T, c.1657C>T and c.2551C>T and the frameshift variant c.1367delT were predicted to introduce premature stop codon and produce shorten CFTR protein, which was also first validated by in vitro truncation assay in this study. The missense variant c.1810A>C was predicted to disrupt the function of the nucleotide-binding domain 1 (NBD1) in the CFTR protein. The splicing variant c.1766+5G>T caused skipping of exon 13 and damaged the integrity of CFTR protein. Conclusions Our study expands the spectrum of phenotypes and genotypes for CF of Chinese origin, which differs significantly from that of Caucasian. Genetic analysis and counseling are crucial and deserve extensive popularization for the diagnosis of CF in patients of Chinese origin.

Complete CFTR Gene Sequencing in 5,058 Individuals with Cystic Fibrosis Informs Variant-Specific Treatment.

Genomic Rearrangements in the Cftr Gene: Extensive Allelic Heterogeneity and Diverse Mutational Mechanisms

High-quality Read-Based Phasing of Cystic Fibrosis Cohort Informs Genetic Understanding of Disease Modification

Genetic analysis and functional study of novel CFTR variants in Chinese children with cystic fibrosis

Whole-Exome Sequencing Identified CFTR Variants in Two Consanguineous Families in China

Genetic Modifiers of Cystic Fibrosis Lung Disease Severity

Accounting for Population Structure in Genetic Studies of Cystic Fibrosis.

In vitro modulator responsiveness of 655 CFTR variants found in people with cystic fibrosis

Phenotypic Evaluation of Rare Cystic Fibrosis Transmembrane Conductance Regulator Mutation Combinations in People with Cystic Fibrosis in Queensland, Australia

Exploring Turkey's mosaic of novel variants and complex alleles in cystic fibrosis genetics

Genetic Evidence Supports the Development of SLC26A9 Targeting Therapies for the Treatment of Lung Disease

Functional Consequences of CFTR Interactions in Cystic Fibrosis

Current landscape of cystic fibrosis gene therapy

Genome-wide Association Meta-Analysis Identifies Five Modifier Loci of Lung Disease Severity in Cystic Fibrosis

Cystic Fibrosis Gene Modifierslc26a9modulates Airway Response to CFTR-directed Therapeutics

Novel Mutations and Polymorphisms in the CFTR Gene Associated with Three Subtypes of Congenital Absence of Vas Deferens.

Precision medicine advances in cystic fibrosis: Exploring genetic pathways for targeted therapies

Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation

Diversity of CFTR variants across ancestries characterized using 454,727 UK biobank whole exome sequences

Multisite Verification of a Targeted CFTR Polymerase Chain Reaction/Capillary Electrophoresis Assay That Evaluates Pathogenic Variants Across Diverse Ethnic and Ancestral Groups

Compound heterozygous CFTR variants (Q1352H and 5T; TG13) in a Chinese patient with cystic fibrosis